Targeting mutant BRAF in colorectal cancer

Targeting mutant BRAF in colorectal cancer

Bibliographic Details
Main Authors:	Carroll David, Carson R, Van Schaeybroeck S, Johnston PG
Format:	Article
Language:	English
Published:	BMC 2013-01-01
Series:	BMC Proceedings

Similar Items

Targeting BRAF and RAS in Colorectal Cancer
by: Helene Bellio, et al.
Published: (2021-05-01)

Chromosomal instability in BRAF mutant, microsatellite stable colorectal cancers.
by: Catherine E Bond, et al.
Published: (2012-01-01)

Current Therapeutic Strategies in BRAF-Mutant Metastatic Colorectal Cancer
by: Elisa Grassi, et al.
Published: (2021-06-01)

Establishment of a 3D tumour model and targeted therapy of BRAF-mutant colorectal cancer
by: Baur, Florentin Philipp
Published: (2019)

Development of small-molecule therapeutics and strategies for targeting RAF kinase in BRAF-mutant colorectal cancer
by: Pan JH, et al.
Published: (2018-08-01)

BRAF Inhibitors for BRAF V600E Mutant Colorectal Cancers: Literature Survey and Case Report
by: Yasar Subutay Peker, et al.
Published: (2018-01-01)

Incidence and prognostic factors in patents (pts) with mutant BRAF (mBRAF) metastatic colorectal cancer (mCRC) in Russia
by: M. Yu. Fedyanin, et al.
Published: (2021-06-01)

Mutant-selective degradation by BRAF-targeting PROTACs
by: Shanique Alabi, et al.
Published: (2021-02-01)

Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan
by: Tatsuki Ikoma, et al.
Published: (2021-05-01)

BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors
by: Evelina Miele, et al.
Published: (2020-02-01)

Identification of anticancer drugs to radiosensitise <i>BRAF</i>-wild-type and mutant colorectal cancer
by: Rebecca Carter, et al.
Published: (2019-06-01)

Targeting BRAF-Mutant Biliary Tract Cancer: Recent Advances and Future Challenges
by: Alessandro Rizzo MD, et al.
Published: (2020-12-01)

Agents to treat BRAF-mutant lung cancer
by: Jean G Bustamante Alvarez, et al.
Published: (2019-03-01)

FOLFOXIRI versus FOLFOX or FOLFIRI with targeted therapy in patients with mutant BRAF metastatic colorectal cancer: A systematic review and meta-analysis
by: M. Yu. Fedyanin, et al.
Published: (2020-12-01)

<em>APC</em> Mutation Marks an Aggressive Subtype of <em>BRAF </em>Mutant Colorectal Cancers
by: Lochlan J. Fennell, et al.
Published: (2020-05-01)

AIM2 Inhibits BRAF-Mutant Colorectal Cancer Growth in a Caspase-1-Dependent Manner
by: Shailendra Shah, et al.
Published: (2021-03-01)

Dabrafenib for treatment of BRAF-mutant melanoma
by: Kainthla R, et al.
Published: (2013-12-01)

Combined targeting of BRAF and CRAF or BRAF and PI3K effector pathways is required for efficacy in NRAS mutant tumors.
by: Bijay S Jaiswal, et al.
Published: (2009-05-01)

Molecular targeted therapy of -mutant colorectal cancer
by: Michel Ducreux, et al.
Published: (2019-06-01)

A Novel Polyamine-Targeted Therapy for BRAF Mutant Melanoma Tumors
by: Molly C. Peters, et al.
Published: (2018-01-01)

<i>BRAF</i> Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation
by: Izuma Nakayama, et al.
Published: (2020-11-01)

The role of autophagy in the treatment of BRAF mutant colorectal carcinomas differs based on microsatellite instability status.
by: Evangelos Koustas, et al.
Published: (2018-01-01)

The Evolutionary Landscape of Treatment for <i>BRAF<sup>V600E</sup></i> Mutant Metastatic Colorectal Cancer
by: Gianluca Mauri, et al.
Published: (2021-01-01)

The Role of Anti-Angiogenics in Pre-Treated Metastatic <i>BRAF</i>-Mutant Colorectal Cancer: A Pooled Analysis
by: Fabio Gelsomino, et al.
Published: (2020-04-01)

BRAF Mutated Colorectal Cancer: New Treatment Approaches
by: Javier Molina-Cerrillo, et al.
Published: (2020-06-01)

BRAF-Mutated Colorectal Cancer: Clinical and Molecular Insights
by: Francesco Caputo, et al.
Published: (2019-10-01)

Molecular understanding of KRAS- and BRAF-mutated colorectal cancers
by: Lundberg, Ida
Published: (2017)

Clinical responses to ERK inhibition in BRAF V600E-mutant colorectal cancer predicted using a computational model
by: Daniel C. Kirouac, et al.
Published: (2017-06-01)

Alterations in signaling pathways that accompany spontaneous transition to malignancy in a mouse model of BRAF mutant microsatellite stable colorectal cancer
by: Alexandra M. Kane, et al.
Published: (2020-02-01)

Current Advances in the Treatment of BRAF-Mutant Melanoma
by: Hima Patel, et al.
Published: (2020-02-01)

Targeted Disruption of V600E-Mutant BRAF Gene by CRISPR-Cpf1
by: Meijia Yang, et al.
Published: (2017-09-01)

Clinicopathologic Features and Prognosis of BRAF Mutated Colorectal Cancer Patients
by: Wen-Long Guan, et al.
Published: (2020-11-01)

Towards a molecular classification of colorectal cancer: The role of BRAF
by: Alexandra eThiel, et al.
Published: (2013-11-01)

Oncogenic KRAS and BRAF Drive Metabolic Reprogramming in Colorectal Cancer
by: Hutton, Josiah Ewing
Published: (2016)

The Possible Therapeutic Strategy for Colorectal Cancer with KRAS/BRAF Mutations
by: Jing-Jung Chen, et al.
Published: (2012)

Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer
by: Kevin J Harrington, et al.
Published: (2020-07-01)

The association between BRAF mutation class and clinical features in BRAF-mutant Chinese non-small cell lung cancer patients
by: Quan Lin, et al.
Published: (2019-08-01)

VCAM-1 Upregulation Contributes to Insensitivity of Vemurafenib in BRAF-Mutant Thyroid Cancer
by: Shitu Chen, et al.
Published: (2020-02-01)

Degree of Tissue Differentiation Dictates Susceptibility to BRAF-Driven Colorectal Cancer
by: Kevin Tong, et al.
Published: (2017-12-01)

Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma
by: Ernesto Rossi, et al.
Published: (2019-04-01)